Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
138M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
45.4M
-
Shares change
-
+213K
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
+$3.61M
-
Number of buys
-
47
-
Number of sells
-
-42
-
Price
-
$23.77
Significant Holders of Avidity Biosciences, Inc. - COMMON STOCK (RNA) as of Q4 2021
119 filings reported holding RNA - Avidity Biosciences, Inc. - COMMON STOCK as of Q4 2021.
Avidity Biosciences, Inc. - COMMON STOCK (RNA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.4M shares
of 138M outstanding shares and own 32.93% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.73M shares), RTW INVESTMENTS, LP (4.8M shares), FMR LLC (3.78M shares), BlackRock Inc. (3.3M shares), EcoR1 Capital, LLC (2.76M shares), FEDERATED HERMES, INC. (2.47M shares), Cormorant Asset Management, LP (2.01M shares), VANGUARD GROUP INC (2M shares), Avidity Partners Management LP (1.82M shares), and STATE STREET CORP (1.4M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.